Biomarin Pharmaceutical Inc (BMRN) — Free Cash Flow Generation Index
Biomarin Pharmaceutical Inc (BMRN) has a Free Cash Flow Generation Index of 0.91x as of March 2026. Free cash flow of $199.73 Million represents 1% of operating cash flow ($220.65 Million). Read how much debt does Biomarin Pharmaceutical Inc carry for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Biomarin Pharmaceutical Inc Free Cash Flow Generation Index (2009–2025)
Historical FCF Generation Index trend for Biomarin Pharmaceutical Inc across 12 annual periods. Explore BMRN capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Biomarin Pharmaceutical Inc (2009–2025)
Year-by-year Free Cash Flow Generation Index for Biomarin Pharmaceutical Inc. For the full company profile including market capitalisation, see BMRN company net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.88x | $724.96 Million | $827.99 Million | $103.04 Million | ▲ +5.5% |
| 2024 | 0.83x | $475.42 Million | $572.84 Million | $97.42 Million | ▲ +111.3% |
| 2023 | 0.39x | $62.57 Million | $159.26 Million | $96.69 Million | ▲ +25.8% |
| 2022 | 0.31x | $54.94 Million | $175.90 Million | $120.96 Million | ▼ -48.7% |
| 2021 | 0.61x | $185.31 Million | $304.54 Million | $119.22 Million | ▲ +199.6% |
| 2020 | -0.61x | $-52.15 Million | $85.36 Million | $137.52 Million | ▲ +69.5% |
| 2019 | -2.00x | $-96.76 Million | $48.26 Million | $145.03 Million | ▲ +67.4% |
| 2018 | -6.16x | $-124.41 Million | $20.21 Million | $144.62 Million | ▼ -302.1% |
| 2012 | -1.53x | $-26.96 Million | $17.61 Million | $44.57 Million | ▲ +78.8% |
| 2011 | -7.22x | $-135.47 Million | $18.75 Million | $154.22 Million | ▼ -340.9% |
| 2010 | -1.64x | $-30.71 Million | $18.75 Million | $49.46 Million | ▼ -6847.7% |
| 2009 | -0.02x | $-2.07 Million | $87.73 Million | $89.80 Million | — |